Skip to main content
Fig. 2 | Journal of Translational Medicine

Fig. 2

From: Clinical utility of cerebrospinal fluid-derived circular RNAs in lung adenocarcinoma patients with brain metastases

Fig. 2

Characteristic of the sixty CSF-circRNAs and their association with the clinical outcome. A Flowchart for screening human lung cancer brain metastasis-related cerebrospinal fluid circRNAs. B The number (above) and expression abundance (below) of 60 identified cerebrospinal fluid circRNAs in each lung cancer brain metastasis patient. The intense of red color in the heatmap implicated the expression abundance of specific circRNA in the patient. C Overall survival of all patients enrolled. Survival curve was drawn by Kaplan-Meyer analysis to estimate median survival time. NR: not reached. D Kaplan–Meier overall survival curves of lung cancer brain metastasis patients according to 60 CSF circRNAs. E Correlation between the number of CSF-circRNAs and tumor size

Back to article page